Agios Pharmaceuticals (AGIO) FCF Margin (2012 - 2026)
Agios Pharmaceuticals (AGIO) posted FCF Margin of 576.93% for Q1 2026, down 19.79% on a QoQ basis from 481.59% in Q4 2025, and up 70952.0% year-over-year from N/an in Q1 2025.
Agios Pharmaceuticals (AGIO) FCF Margin (2012 - 2026) Analysis & Trends
Agios Pharmaceuticals' FCF Margin history runs 14 years deep, the most recent figure standing at 576.93% for Q1 2026.
- Quarterly FCF Margin rose 70952.0% year-over-year to 576.93% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 576.39% (up 51424.0% YoY) and the FY2025 annual result came in at 690.86%, up 38187.0% from the prior year.
- FCF Margin was 576.93% for Q1 2026 at Agios Pharmaceuticals, down from 481.59% in the prior quarter.
- Across five years, FCF Margin topped out at 481.59% in Q4 2025 and bottomed at 12084.01% in Q1 2022.
- A 5-year average of 1730.64% and a median of 1034.39% in 2023 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin jumped 1037993 bps — and 2024, when it sank 22181 bps.
- Agios Pharmaceuticals' FCF Margin stood at 1428.14% in 2022, then gained by 28 bps to 1034.39% in 2023, then decreased by 21 bps to 1256.21% in 2024, then surged by 62 bps to 481.59% in 2025, then fell by 20 bps to 576.93% in 2026.
- Business Quant data shows AGIO's FCF Margin at 576.93% in Q1 2026, 481.59% in Q4 2025, and 674.27% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | -576.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -576.93% |
| Dec 31, 2025 | -481.59% |
| Sep 30, 2025 | -674.27% |
| Jun 30, 2025 | -626.25% |
| Mar 31, 2025 | -1,286.44% |
| Dec 31, 2024 | -1,256.21% |
| Sep 30, 2024 | -939.73% |
| Jun 30, 2024 | -843.08% |
| Mar 31, 2024 | -1,219.53% |
| Dec 31, 2023 | -1,034.39% |
| Sep 30, 2023 | -833.23% |
| Jun 30, 2023 | -988.60% |
| Mar 31, 2023 | -1,704.08% |
| Dec 31, 2022 | -1,428.14% |
| Sep 30, 2022 | -2,164.62% |
| Jun 30, 2022 | -1,279.76% |
| Mar 31, 2022 | -12,084.01% |
| Dec 31, 2020 | 23.83% |
| Sep 30, 2020 | -331.63% |
| Jun 30, 2020 | -77.68% |